Free Trial

Aclarion (ACON) Competitors

Aclarion logo
$0.18 +0.00 (+0.51%)
(As of 10:46 AM ET)

ACON vs. ATIP, KDLY, MGRX, ATPC, BGLC, VSEE, CMAX, NIVF, BACK, and GBNHF

Should you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include ATI Physical Therapy (ATIP), Kindly MD (KDLY), Mangoceuticals (MGRX), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), CareMax (CMAX), NewGenIvf Group (NIVF), IMAC (BACK), and Greenbrook TMS (GBNHF). These companies are all part of the "healthcare" industry.

Aclarion vs.

Aclarion (NASDAQ:ACON) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings.

In the previous week, Aclarion had 2 more articles in the media than ATI Physical Therapy. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for ATI Physical Therapy. Aclarion's average media sentiment score of 1.50 beat ATI Physical Therapy's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.

Company Overall Sentiment
Aclarion Very Positive
ATI Physical Therapy Neutral

ATI Physical Therapy has a net margin of -7.79% compared to Aclarion's net margin of -12,845.05%. ATI Physical Therapy's return on equity of 0.00% beat Aclarion's return on equity.

Company Net Margins Return on Equity Return on Assets
Aclarion-12,845.05% -422.87% -201.15%
ATI Physical Therapy -7.79%N/A -3.87%

Aclarion has higher earnings, but lower revenue than ATI Physical Therapy.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$80K23.12-$4.91MN/AN/A
ATI Physical Therapy$699.02M0.01-$69.79M-$18.57-0.08

Aclarion has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500.

Aclarion currently has a consensus price target of $1.50, suggesting a potential upside of 746.02%. Given Aclarion's stronger consensus rating and higher possible upside, research analysts plainly believe Aclarion is more favorable than ATI Physical Therapy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aclarion
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ATI Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

7.5% of Aclarion shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 1.7% of Aclarion shares are owned by company insiders. Comparatively, 3.3% of ATI Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ATI Physical Therapy received 12 more outperform votes than Aclarion when rated by MarketBeat users. However, 100.00% of users gave Aclarion an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.

CompanyUnderperformOutperform
AclarionOutperform Votes
3
100.00%
Underperform Votes
No Votes
ATI Physical TherapyOutperform Votes
15
36.59%
Underperform Votes
26
63.41%

Summary

Aclarion and ATI Physical Therapy tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACON vs. The Competition

MetricAclarionMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$1.85M$3.07B$5.08B$8.80B
Dividend YieldN/A11.18%5.02%4.07%
P/E RatioN/A9.0391.2813.60
Price / Sales23.12215.431,226.2187.40
Price / CashN/A406.7839.4536.27
Price / Book0.743.206.906.33
Net Income-$4.91M-$32.86M$118.83M$225.93M
7 Day Performance4.36%0.59%-1.92%-0.96%
1 Month Performance-9.08%-0.23%-3.75%1.06%
1 Year Performance-96.28%25.97%31.37%26.59%

Aclarion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACON
Aclarion
2.6062 of 5 stars
$0.18
+0.5%
$1.50
+746.0%
-95.9%$1.85M$80,000.000.007News Coverage
Positive News
ATIP
ATI Physical Therapy
0.224 of 5 stars
$1.56
-1.9%
N/A-78.2%$6.88M$699.02M0.005,600
KDLY
Kindly MD
0.1582 of 5 stars
$1.05
+15.4%
N/AN/A$6.28MN/A0.00N/AGap Up
MGRX
Mangoceuticals
0.508 of 5 stars
$2.41
-2.4%
N/A-98.1%$6.00M$730,000.000.003Gap Down
ATPC
Agape ATP
0.013 of 5 stars
$1.48
+2.8%
N/A-92.4%$5.91M$1.43M0.0040
BGLC
BioNexus Gene Lab
N/A$0.29
-3.3%
N/A-22.6%$5.21M$9.77M0.0030
VSEE
Vsee Health
0.3541 of 5 stars
$1.33
+0.8%
N/AN/A$4.79MN/A0.00N/ANews Coverage
Gap Up
CMAX
CareMax
1.0108 of 5 stars
$0.79
+6.8%
N/A-97.4%$3.02M$751.10M0.001,450
NIVF
NewGenIvf Group
1.6259 of 5 stars
$0.55
-7.5%
N/AN/A$2.05M$5.14M0.00N/A
BACK
IMAC
N/A$1.02
-1.0%
N/A-29.9%$1.17M$16.19M0.00180
GBNHF
Greenbrook TMS
N/A$0.02
flat
N/AN/A$636,000.00$73.79M0.00430

Related Companies and Tools


This page (NASDAQ:ACON) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners